Blue Wolf Capital to Acquire OSD CDMO Sites from Recipharm

Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the healthcare and industrial sectors, announces that it has committed, subject to regulatory clearances, to acquire seven manufacturing and development facilities: Solna, Stängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain, from Recipharm, a contract development and manufacturing organization (“CDMO”) headquartered in Stockholm. The seven facilities have been a part of Recipharm for over a decade and have focused on the manufacturing and development of oral solid, semi-solid and liquid dosage form pharmaceutical products. The facilities serve over 120 customers around the world and have a strong track record of quality and regulatory compliance.

Read the full article: Blue Wolf Capital to Acquire OSD CDMO Sites from Recipharm //

Source: https://www.businesswire.com/news/home/20240402076935/en/Blue-Wolf-Capital-to-Acquire-OSD-CDMO-Sites-from-Recipharm

Leave a Comment

Your email address will not be published.

Scroll to Top